Pereiti į pagrindinį turinį
Home
language-selector-globe Lithuania | lt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Lithuania
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Terapinės sritys 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Gydytojas tikrina paciente su stratoskopu Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera Karjera
    • Koronavirusas 
      coronavirus-microscope-image Koronavirusas
    Vilniaus panorama Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjera
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas
  • Svetainė Sort ascending
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Svetainė Sort ascending Vieta Padalinys Veikla Functional Area Paskelbimo data
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Rug 02, 2024
Medical Affairs Lead Specialty Warsaw Poland International Innovative Medicines Research & Development Spa 11, 2024
Medical Science Liaison Lead Warsaw Poland International Innovative Medicines Research & Development Bal 18, 2024
Medical Advisor In Market Brands Vilvoorde Belgium International Innovative Medicines Research & Development Spa 03, 2024
Senior Regulatory Affairs Manager Vietnam Vietnam Development Innovative Medicines Research & Development Spa 08, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Rug 03, 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Bal 18, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Gegužė 30, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Bir 20, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Lie 15, 2024
Associate Clinical Development Medical Director Shanghai (Shanghai) China Development Innovative Medicines Research & Development Rugp 22, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Lie 29, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Spa 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Spa 18, 2024
MSL Manager - Hematology Shanghai (Shanghai) China International Innovative Medicines Research & Development Gegužė 14, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Rug 11, 2024
(Senior) MSL Manager, LC Shanghai (Shanghai) China International Innovative Medicines Research & Development Rug 18, 2024
(Sr.) Medical Advisor, LC Shanghai (Shanghai) China International Innovative Medicines Research & Development Spa 18, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Rug 01, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Rug 05, 2024
Franchise Medical Head – Cardiovascular and Metabolism Seoul South Korea International Innovative Medicines Research & Development Spa 07, 2024
Associate Director Data & Digitalization Project Management Schaftenau Austria Development Innovative Medicines Research & Development Rug 03, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Rug 02, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Rug 02, 2024
Senior Expert Engineering, Device Development Schaftenau Austria Development Innovative Medicines Research & Development Rug 03, 2024
Associate Director, Technical Transfer Team - Medical Devices Schaftenau Austria Development Innovative Medicines Research & Development Rug 03, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Rug 30, 2024
Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen Saxony (with Corpus Christi) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Spa 18, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Lie 16, 2024
Gerente de Operações Estratégicas e Compliance Jr. Santo Amaro Brazil Development Innovative Medicines Research & Development Spa 18, 2024
Research Scientist I San Diego USA Biomedical Research Pharma Research Research & Development Lie 24, 2024
Senior Scientist – In vitro Pharmacology - Gene Therapy San Diego USA Biomedical Research Pharma Research Research & Development Lie 24, 2024
Research Scientist II San Diego USA Biomedical Research Pharma Research Research & Development Spa 01, 2024
Senior Scientist I/II, Structural Biologics San Diego USA Biomedical Research Pharma Research Research & Development Spa 01, 2024
Principal Scientist II, Cell & Gene Therapy Delivery San Diego USA Biomedical Research Pharma Research Research & Development Spa 17, 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development Bir 02, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Rugp 29, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North Remote USA US Innovative Medicines Research & Development Bir 05, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentina Development Innovative Medicines Research & Development Rugp 15, 2024
Patient Advocacy Manager Prague Czech Republic International Innovative Medicines Research & Development Spa 10, 2024
Patient Advocacy & Medical Lead Prague Czech Republic International Innovative Medicines Research & Development Spa 10, 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development Rug 27, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Rug 04, 2024
RWE Lead H/F CDD 12 mois Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Research & Development Spa 04, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Spa 17, 2024
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Rug 06, 2024
Medical Content Lead (m/w/d), Hematology Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Rug 09, 2024
Project Team Coordinator (Medical) (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Spa 15, 2024
Medical Science Liaison Hemato (Siberia) Novosibirsk Russian Fed. International Innovative Medicines Research & Development Rug 20, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Spa 06, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Musų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2024 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams